|
|
| GeneID |
7508
|
| Symbol |
XPC
|
| Synonyms |
XP3|XPCC
|
| Description |
xeroderma pigmentosum, complementation group C |
| See related |
HGNC:12816|MIM:278720|Ensembl:ENSG00000154767|HPRD:02046| |
| Locus tag |
- |
| Gene type |
protein-coding |
| Map location |
3p25 |
|
| |
|
|
| Gene set name |
Method of gene set |
Evidence |
Info |
| GSMA_I | genome scan meta-analysis | Psr: 0.006 | |
|
| |
| General Gene Expression (microarray) ? |
|
 |
| |
| Gene Expression in Brain Regions (new) |
|
| |
| Top co-expressed genes in Brain Regions (new) |
|
| Gene | Pearson's Correlation | Spearman's Correlation | | |
| Top 10 positively co-expressed genes |
| ZSCAN21 | 0.97 | 0.94 | | |
| NVL | 0.95 | 0.92 | | |
| TRA2A | 0.95 | 0.91 | | |
| BAT1 | 0.95 | 0.90 | | |
| SSRP1 | 0.95 | 0.90 | | |
| ZNF671 | 0.95 | 0.90 | | |
| WTAP | 0.94 | 0.90 | | |
| EPC1 | 0.94 | 0.89 | | |
| SETDB1 | 0.94 | 0.92 | | |
| ZNF34 | 0.94 | 0.91 | | |
Top 10 negatively co-expressed genes | | HLA-F | -0.74 | -0.74 | | |
| C5orf53 | -0.72 | -0.69 | | |
| AIFM3 | -0.72 | -0.74 | | |
| AF347015.31 | -0.72 | -0.85 | | |
| AF347015.27 | -0.72 | -0.84 | | |
| PTH1R | -0.72 | -0.73 | | |
| FBXO2 | -0.71 | -0.66 | | |
| MT-CO2 | -0.71 | -0.85 | | |
| AF347015.33 | -0.70 | -0.82 | | |
| IFI27 | -0.70 | -0.84 | | |
|
| Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0003684 | damaged DNA binding | TAS | | 10873465 |
| GO:0003697 | single-stranded DNA binding | TAS | | 8168482 |
| GO:0005515 | protein binding | IPI | | 15231747 |18024891 |
| Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0000075 | cell cycle checkpoint | IMP | | 17088560 |
| GO:0000718 | nucleotide-excision repair, DNA damage removal | EXP | | 10583946 |
| GO:0010224 | response to UV-B | IEA | | - |
| GO:0031573 | intra-S DNA damage checkpoint | IEA | | - |
| Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0005634 | nucleus | IEA | | - |
| GO:0005654 | nucleoplasm | EXP | | 10214908 |
| |
|
|
| |